Asthma: symptoms and diagnosis [sounds like]
28 results
1 - 28
Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma- Workplace interventions for treatment of occupational asthma
- Vitamins C and E for asthma and exercise‐induced bronchoconstriction
- Vitamin C for asthma and exercise‐induced bronchoconstriction
- Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma
- Exhaled nitric oxide levels to guide treatment for adults with asthma
- Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
- Oral and intranasal aspirin desensitisation for non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease
- Pulse oximeters to self monitor oxygen saturation levels as part of a personalised asthma action plan for people with asthma
- Exhaled nitric oxide levels to guide treatment for children with asthma
- Cognitive behavioural therapy (CBT) for adults and adolescents with asthma
- Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma
- Beta2‐agonists for acute cough or a clinical diagnosis of acute bronchitis
- Vilanterol and fluticasone furoate for asthma
- Sublingual immunotherapy for asthma
- Breathing exercises for dysfunctional breathing/hyperventilation syndrome in children
- Digital interventions to improve adherence to maintenance medication in asthma
- Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
- Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review
- Inhaled corticosteroids for the treatment of COVID‐19
- Self‐management for bronchiectasis
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
- Speech and language therapy for management of chronic cough
- Neuraminidase inhibitors for preventing and treating influenza in adults and children